Published in Gut on March 01, 2007
Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner. Clin Exp Metastasis (2007) 0.90
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. J Immunother Cancer (2016) 0.75
A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87
Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell (1997) 6.70
Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med (1998) 4.16
Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem (2001) 2.91
Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum (2001) 1.87
Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science (2000) 1.70
A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol (2000) 1.49
In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med (1998) 1.46
Fractalkine-mediated endothelial cell injury by NK cells. J Immunol (2000) 1.34
Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int (1999) 1.25
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler Thromb Vasc Biol (2005) 1.22
The high expression of Fractalkine results in a better prognosis for colorectal cancer patients. Int J Oncol (2005) 1.13
Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. Blood (2001) 1.03
Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors. Eur J Immunol (2006) 0.99
Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer. Gut (2006) 0.99
Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses. Int J Clin Lab Res (1998) 0.90
Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine/CX3CL1. Immunol Lett (2003) 0.86
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J (2002) 3.01
Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation (2010) 2.53
Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet (1994) 2.39
KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet (1997) 1.90
De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation (2001) 1.88
Incidence and clinical significance of left ventricular thrombus in tako-tsubo cardiomyopathy assessed with echocardiography. QJM (2008) 1.71
Targeting the slow pathway for atrioventricular nodal reentrant tachycardia: initial results and long-term follow-up in 379 consecutive patients. Eur Heart J (2001) 1.71
Predictors of in-hospital mortality after DC catheter ablation of atrioventricular junction. Results of a prospective, international, multicenter study. Circulation (1991) 1.64
Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation (1992) 1.61
An anatomically and electrogram-guided stepwise approach for effective and safe catheter ablation of the fast pathway for elimination of atrioventricular node reentrant tachycardia. J Am Coll Cardiol (1995) 1.61
Erroneous discharge of an implantable cardioverter defibrillator caused by an electric razor. Pacing Clin Electrophysiol (1995) 1.54
Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J (2000) 1.52
Intraoperative radiofrequency ablation of chronic atrial fibrillation: a left atrial curative approach by elimination of anatomic "anchor" reentrant circuits. J Cardiovasc Electrophysiol (1999) 1.52
Is there a need for routine testing of ICD defibrillation capacity? Results from more than 1000 studies. Eur Heart J (2000) 1.51
Extracardiac contributions to chest pain perception in patients 6 months after acute myocardial infarction. Am Heart J (1999) 1.50
Haemodynamic quantification of different provocation manoeuvres by simultaneous measurement of right and left atrial pressure: implications for the echocardiographic detection of persistent foramen ovale. Eur J Echocardiogr (2001) 1.47
Successful radiofrequency catheter ablation of right sided accessory pathways during sustained atrial fibrillation. Eur Heart J (1995) 1.47
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J (2001) 1.46
Doppler echocardiographic assessment of the pressure gradient during bicycle ergometry in hypertrophic cardiomyopathy. Am J Cardiol (1992) 1.43
Temperature-controlled radiofrequency catheter ablation of manifest accessory pathways. Eur Heart J (1996) 1.39
Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. Eur Heart J (1991) 1.39
Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope: results of programmed ventricular stimulation and long-term follow-up. Circulation (1997) 1.39
Effects of enflurane on inducibility of ventricular tachycardia. Am J Cardiol (1991) 1.38
Implantable cardioverter/defibrillators (ICD): a new lead-system using transvenous-subcutaneous approach in patients with prior cardiac surgery. Eur J Cardiothorac Surg (1991) 1.38
ESCWGA/NASPE/P experts consensus statement: living anatomy of the atrioventricular junctions. A guide to electrophysiologic mapping. Working Group of Arrhythmias of the European Society of Cardiology. North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol (1999) 1.37
The LQT syndromes--current status of molecular mechanisms. Z Kardiol (1999) 1.18
Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy. Circulation (1994) 1.17
Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure. Circulation (1998) 1.16
Prognostic significance of late ventricular potentials after acute myocardial infarction. Eur Heart J (1983) 1.15
Aortic valve calcification: basic science to clinical practice. Heart (2008) 1.12
Experimental models of torsade de pointes. Cardiovasc Res (1998) 1.11
Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J (1994) 1.09
Biphasic defibrillation using a single capacitor with large capacitance: reduction of peak voltages and ICD device size. Pacing Clin Electrophysiol (1996) 1.08
The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study. Circulation (1982) 1.06
Pacemaker-induced ventricular tachycardia in normally functioning ventricular demand pacemakers. Am J Cardiol (1989) 1.06
CMR-derived TAPSE measurement: a semi-quantitative method of right ventricular function assessment in patients with hypertrophic cardiomyopathy. Neth Heart J (2014) 1.05
Radiofrequency coagulation of ventricular myocardium: improved prediction of lesion size by monitoring catheter tip temperature. Eur Heart J (1989) 1.04
Variant form of the acute apical ballooning syndrome (takotsubo cardiomyopathy): observations on a novel entity. Heart (2006) 1.02
Brugada syndrome and supraventricular tachyarrhythmias: a novel association? J Cardiovasc Electrophysiol (2001) 1.02
QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart (2003) 1.02
Variants of preexcitation--specialized atriofascicular pathways, nodofascicular pathways, and fasciculoventricular pathways: electrophysiologic findings and target sites for radiofrequency catheter ablation. J Cardiovasc Electrophysiol (1996) 1.01
Localization and radiofrequency catheter ablation of left-sided accessory pathways during atrial fibrillation. Feasibility and electrogram criteria for identification of appropriate target sites. J Am Coll Cardiol (1995) 1.00
Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.98
Wolff-Parkinson-White syndrome associated with Brugada syndrome. Pacing Clin Electrophysiol (2001) 0.98
Impact of radiofrequency catheter ablation of accessory pathways on the frequency of atrial fibrillation during long-term follow-up; high recurrence rate of atrial fibrillation in patients older than 50 years of age. Eur Heart J (2001) 0.98
Atrioventricular nodal reentry tachycardia: electrophysiologic comparisons in patients with and without 2:1 infra-His block. Clin Cardiol (1993) 0.97
Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis. Z Kardiol (2004) 0.97
High frequency alternating current ablation of an accessory pathway in humans. J Am Coll Cardiol (1987) 0.96
Value of intravascular ultrasound in the diagnosis and characterization of patent ductus arteriosus in an adult patient. Eur Heart J (1993) 0.96
Autosomal recessive long-QT syndrome (Jervell Lange-Nielsen syndrome) is genetically heterogeneous. Hum Genet (1997) 0.95
Intravascular electric impedance spectroscopy of atherosclerotic lesions using a new impedance catheter system. Basic Res Cardiol (2005) 0.95
Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging. Heart Rhythm (2011) 0.94
Coagulation of ventricular myocardium using radiofrequency alternating current: bio-physical aspects and experimental findings. Pacing Clin Electrophysiol (1989) 0.94
Idiopathic left ventricular tachycardia: new insights into electrophysiological characteristics and radiofrequency catheter ablation. Pacing Clin Electrophysiol (1995) 0.94
Do patients with an implantable defibrillator live longer? J Am Coll Cardiol (1993) 0.93
A hybrid approach for quantification of aortic valve stenosis using cardiac magnetic resonance imaging and echocardiography: comparison to right heart catheterization and standard echocardiography. Clin Res Cardiol (2006) 0.93
Arrhythmias in heart failure: current concepts of mechanisms and therapy. J Cardiovasc Electrophysiol (2000) 0.93
Midwall myocardial fibrosis in Becker-Kiener muscular dystrophy. Z Kardiol (2005) 0.92
Coincidence of coronary artery disease and Tako-Tsubo cardiomyopathy. Herz (2010) 0.91
Arrhythmias in hypertrophic obstructive and non-obstructive cardiomyopathy. Eur Heart J (1983) 0.91
Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis. Inflamm Res (2004) 0.91
Radiofrequency catheter ablation of accessory pathways. Outcome and use of antiarrhythmic drugs during follow-up. Eur Heart J (1999) 0.91
Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias. J Cardiovasc Pharmacol (1991) 0.90
Comparison of impedance cardiography and thermodilution-derived measurements of stroke volume and cardiac output at rest and during exercise testing. Cardiovasc Drugs Ther (2005) 0.89
Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions. J Am Coll Cardiol (1998) 0.88
Unexpected emergence of manifest preexcitation following transcatheter ablation of concealed accessory pathways. J Cardiovasc Electrophysiol (1993) 0.88
Prognosis and risk stratification after myocardial infarction. Eur Heart J (1995) 0.88
Molecular analysis at the Harvey Ras-1 gene in patients with long QT syndrome. J Mol Med (Berl) (1995) 0.88
Pathophysiological mechanisms and clinical significance of ventricular late potentials. Eur Heart J (1986) 0.87
Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.87
Modification of stretch-induced shortening of repolarization by streptomycin in the isolated rabbit heart. J Cardiovasc Pharmacol (2000) 0.87
Unexplained cardiac arrest. The need for a prospective registry. Eur Heart J (1992) 0.87
Implantation of a dual chamber pacing and sensing single pass defibrillation lead. Pacing Clin Electrophysiol (2001) 0.87
Three-dimensional electromagnetic catheter technology: electroanatomical mapping of the right atrium and ablation of ectopic atrial tachycardia. J Cardiovasc Electrophysiol (1997) 0.87
Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. Eur Heart J (2002) 0.87
Prognostic significance of ventricular late potentials in the postmyocardial infarction period. Herz (1988) 0.86
Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin. J Cardiovasc Pharmacol (1998) 0.86
Ventricular late potentials and inducible ventricular tachyarrhythmias as a marker for ventricular tachycardia after myocardial infarction. Eur Heart J (1986) 0.86
Predictive value of electrophysiologic testing in the treatment of drug-refractory ventricular arrhythmias with amiodarone. Eur Heart J (1986) 0.85
Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. J Am Coll Cardiol (1998) 0.85
Clofilium in the isolated perfused rabbit heart: a new model to study proarrhythmia induced by class III antiarrhythmic drugs. Basic Res Cardiol (1998) 0.85
Radiofrequency catheter ablation of ventricular tachycardia following implantation of an automatic cardioverter defibrillator. Pacing Clin Electrophysiol (1993) 0.84
[Therapy of AV nodal reentry tachycardia with catheter ablation of the fast retrograde pathway]. Z Kardiol (1994) 0.84
[The subcutaneous cardioverter-defibrillator: When less is more]. Herzschrittmacherther Elektrophysiol (2015) 0.84
Paradoxical coronary embolism causing non-ST segment elevation myocardial infarction in a case of pulmonary embolism. Z Kardiol (2004) 0.84
Ultrastructural findings in endomyocardial biopsy of patients with Kearns-Sayre syndrome. J Am Coll Cardiol (1988) 0.84
Pathophysiological mechanisms of ventricular tachyarrhythmias. Eur Heart J (1989) 0.84
Recent advances in the identification of patients at risk of ventricular tachyarrhythmias: role of ventricular late potentials. Circulation (1987) 0.84
Comparison of frequency of aggravation of ventricular tachyarrhythmias after implantation of automatic defibrillators using epicardial versus nonthoracotomy lead systems. Am J Cardiol (1993) 0.84
Results and realistic expectations with transvenous lead systems. Pacing Clin Electrophysiol (1992) 0.83
Ventricular tachycardia caused by cardiac rhabdomyoma in a young adult with tuberous sclerosis. Am Heart J (1996) 0.83
Factors which provoke post-infarction depression: results from the post-infarction late potential study (PILP). J Psychosom Res (1992) 0.83
Surgical treatment of ventricular tachycardias. Complete versus partial encircling endocardial ventriculotomy. J Thorac Cardiovasc Surg (1984) 0.83
Ten years electrophysiologically guided direct operations for malignant ischemic ventricular tachycardia--results. Thorac Cardiovasc Surg (1989) 0.83
Characteristics of local electrogram predicting successful transcatheter radiofrequency ablation of left-sided accessory pathways. J Am Coll Cardiol (1992) 0.83